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Abstract 
Background: Socioeconomic and racial/ethnic factors strongly influence cardiovascular disease 
outcomes and risk factors. C-reactive protein (CRP), a non-specific marker of inflammation, is 
associated with cardiovascular risk, and knowledge about its distribution in the population may help 
direct preventive efforts. A systematic review was undertaken to critically assess CRP levels 
according to socioeconomic and racial/ethnic factors. 
Methods: Medline was searched through December 2006 for population-based studies examining 
CRP levels among adults with respect to indicators of socioeconomic position (SEP) and/or race/ 
ethnicity. Bibliographies from located studies were scanned and 26 experts in the field were 
contacted for unpublished work. 
Results: Thirty-two relevant articles were located. Cross-sectional (n = 20) and cohort studies (n 
= 11) were included, as was the control group of one trial. CRP levels were examined with respect 
to SEP and race/ethnicity in 25 and 15 analyses, respectively. Of 20 studies that were unadjusted 
or adjusted for demographic variables, 19 found inverse associations between CRP levels and SEP. 
Of 15 similar studies, 14 found differences between racial/ethnic groups such that whites had the 
lowest while blacks, Hispanics and South Asians had the highest CRP levels. Most studies also 
included adjustment for potential mediating variables in the causal chain between SEP or race/ 
ethnicity and CRP. Most of these studies showed attenuated but still significant associations. 
Conclusion: Increasing poverty and non-white race was associated with elevated CRP levels 
among adults. Most analyses in the literature are underestimating the true effects of racial/ethnic 
and socioeconomic factors due to adjustment for mediating factors. 
Background 
The global burden of cardiovascular disease (CVD) repre­
sents the highest cause of mortality and one of the highest 
causes of morbidity both in high-income and low/mid­
dle-income countries [1,2]. It is well known that socioeco­
nomic factors and race/ethnicity influence CVD outcomes 
and risk factors. Studies have consistently found inverse 
and independent associations between socioeconomic 
position (SEP) and the prevalence and incidence of CVD 
[3-8]. Multi-ethnic studies have pointed to significant dif­
ferences between racial/ethnic groups [3,4,7,9,10]. In a 
Canadian study, for example, South Asians were shown to  Page 1 of 12 
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have 6 and 9% higher prevalence of CVD when compared 
to Europeans and Chinese [9], whereas in the US, heart 
disease mortality accounted for up to three times more 
deaths in blacks as compared to Asians [4]. The mecha­
nisms that drive these socio-demographic risk factors to 
influence CVD are not fully understood, as differences in 
body mass index, smoking and other traditional risk fac­
tors fail to totally account for these associations. Therefore 
other mediating factors likely play significant roles in the 
relationship between sociodemographic characteristics 
and CVD. 
Atherosclerosis, the process leading to coronary heart dis­
ease (CHD), has been described as an inflammatory dis­
ease [11]. Over the past decade, low-grade inflammation 
has widely been investigated as a candidate linking the 
association between traditional risk factors and CHD. An 
acute-phase protein produced by hepatocytes, C-reactive 
protein (CRP) has historically been used as a non-specific 
marker for infection, inflammation or tissue damage [12]. 
More recently, highly sensitive assays have permitted eval­
uation of elevated, but not acute, CRP levels in the assess­
ment of risk for several chronic diseases. 
Observational studies show that CRP levels are associated 
with future risk of chronic diseases including CHD [13­
17] and diabetes [18-20] in apparently healthy people. 
Furthermore, CRP has been shown to add to the predic­
tive value of conventional markers such as cholesterol 
[21] and blood pressure [22] in defining risk for coronary 
events. These associations, though consistent, have been 
described to exist to varying degrees. 
Some authors have implicated CRP as an independent 
determinant of the disease process by actively promoting 
the proinflammatory phenotype [23,24]. Others are skep­
tical of this causal association, while not discounting that 
CRP may be proinflammatory under certain circum­
stances [25]. Researchers utilizing Mendelian Randomiza­
tion techniques have found that certain genotypes are 
associated with higher CRP levels but that individuals 
with these genotypes are not necessarily at increased risk 
for cardiovascular events [26-29]. This calls into question 
the assumption that CRP levels are, per se, causally associ­
ated with risk for CHD. Nevertheless, the role of CRP as a 
risk marker is clear. 
In order to adequately investigate the role of inflamma­
tion with respect to the processes that lead to CVD and 
ultimately to design effective interventions in the preven­
tion of CVD based on these principles, the determinants 
of elevated CRP levels should be identified. A systematic 
review of the literature was undertaken to critically assess 
the evidence between socioeconomic and racial/ethnic 
factors and CRP levels among adults. 
Methods 
Search strategy 
Three strategies to locate suitable articles were employed. 
First, the Medline (PubMed) database was searched. The 
main keyword search employed was "(C-reactive protein 
OR CRP OR high-sensitivity C-reactive protein OR hs-
CRP) AND (socioeconomic OR race OR ethnic* OR edu­
cation OR income OR determinants)". Articles published 
through December 2006 were considered. No language 
restrictions were used. Second, reference lists in the stud­
ies identified were scanned and if relevant were sought 
and reviewed. Finally, 26 experts in the field were con­
tacted for unpublished or in-progress work, in addition to 
being contacted for clarification of findings from pub­
lished studies. 
Dependent and independent variables 
The dependent variable was CRP level. Studies using 
either high-sensitivity or conventional CRP assays were 
considered. Studies reporting arithmetic means (or when 
the type of mean is not specified) are described in terms 
of "means" whereas studies reporting geometric means 
are described as such. Authors either log-transformed the 
continuous CRP variable for normality prior to analysis or 
analyzed it as a categorical variable; the methods of one 
study could not be verified (Anand, 2004). 
The independent variables of interest were socioeconomic 
position (SEP) and race/ethnicity. The term socioeco­
nomic position covers a wide range of measures includ­
ing, but not limited to, education, income, possession of 
assets, and index-based measures that inventory a number 
of socioeconomic factors and create a relative score. Stud­
ies that incorporated any socioeconomic variables were 
considered, given that they met the other inclusion crite­
ria. For simplicity, SEP shall be used throughout this 
review when making general references. Studies that ana­
lyzed any racial or ethnic variables such as skin color or 
ethnic background were considered. 
Inclusion criteria 
The review was restricted to population-based studies, 
including those employing methods such as random or 
probability-based sampling based on a given geographical 
area. Studies based on selected sample populations, 
including occupational cohorts, clinic-based or "conven­
ience samples", were not considered. Studies that sampled 
either the entire population or specific age groups were 
included, provided that individuals were aged at least 17 
years. Authors were contacted if sufficient methodological 
or analytical information was not provided in the article 
text or for possible overlapping information from the 
same samples in different articles.  Page 2 of 12 
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Conceptual model for the associations between race/ethnicity, socioeconomic position and C-reactive protein level
1 
Conceptual model 
In epidemiological models, the causal, mediating and 
confounding factors related to risk for disease and disease 
status can be complex to interpret. Conceptual frame­
works aid in the organization of associated proximal and 
distal factors, helping to define which variables may con­
stitute confounders and which ones are likely mediators 
[30]. Most studies are unclear about conceptual models 
used in statistical analyses and interpretations of findings 
[30,31]. 
We proposed a hierarchical model for the factors associ­
ated with CRP levels (Figure 1). In this model, variables 
on higher levels were considered as possible confounders 
for those on lower levels. The arrows represent possible 
pathways. For example, the association between SEP and 
CRP level may be confounded by the variables on level 1, 
since these are independently associated with both the 
dependent (SEP) and independent (CRP level) variables. 
On the other hand, level 3 variables may be on the causal 
pathway from SEP to CRP level and as such are possible 
mediators. In analyzing the association between SEP and 
CRP level, for instance, adjusting for smoking or obesity 
(treating them as confounders) would underestimate the 
true effect of SEP on CRP level by removing the effects 
mediated through smoking and obesity, which are on the 
causal pathway. 
Level 
2 
3 
Results 
Figure 2 shows a flowchart according to QUOROM state­
ment guidelines outlining the number of articles identi­
fied at each step of the literature search [32]. Initial 
searching identified 1146 articles and 460 were retrieved 
for more detail from which 154 potentially appropriate 
articles were reviewed. Eighty-seven studies were 
excluded, primarily because CRP was analyzed as an inde­
pendent variable in prognostic analyses, rather than as an 
outcome. Finally, 35 articles were withdrawn because they 
were not population-based, leaving 32 articles to be 
included in the review. 
These studies were published between 1996 and 2006 and 
were conducted in the USA (14 studies; n = 96746), the 
UK (eight studies; n = 11049), Finland (two studies; n = 
3793), Greece (two studies; n = 5313), Germany (two 
studies; n = 2891), Canada (n = 1250), Italy (n = 1650), 
Turkey (n = 1046) and New Zealand (n = 822). Of these, 
25 analyses included SEP as an independent variable and 
15 included ethnicity/race. Given that eight studies ana­
lyzed both independent variables, Additional file 1 
includes 40 analyses from the 32 included studies. There 
were 20 cross-sectional and 11 cohort studies, all of which 
were analyzed as cross-sectional; two of the latter also 
included retrospective analyses of SEP in early life. One 
article reported on the control group of a larger trial study. 
C-reactive protein level 
HRT (other medications) Obesity Smoking Other mediators 
Age Sex Race/ethnicity Genetic factors 
Socioeconomic position 
Figure 1 
Conceptual model for the associations between race/ethnicity, socioeconomic position and C-reactive protein level.  Page 3 of 12 
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Potentially relevant studies identified: citations
or abstracts screened for retrieval (n= 1146) 
Studies excluded (n= 686) 
Full studies retrieved for more detailed
evaluation (n= 460) 
Studies excluded (n= 306)  

Prognostic studies, CRP used as exposure
 
Potentially appropriate studies to be included
in the analysis (n= 154) 
Studies excluded from analysis (n= 87) 
Not meeting inclusion criteria: Independent variables not 
relevant 
Studies included in analysis (n= 67) 
Studies withdrawn (n= 35)
Not meeting inclusion criteria: Sampling
criteria 
Studies with usable information
(n= 32) 
40 analyses: 
25 Socioeconomic position
15 Ethnicity/race 
Figur  2 
Number of studies associated with process of study selection (according to QUOROM guidelines). 
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Different types of adjustment for covariates were used. In 
light of the conceptual model, analyses that were either 
unadjusted or adjusted for demographic confounding fac­
tors (including age, sex and race/ethnicity) are referred to 
as "minimally adjusted" models. Analyses that also 
included adjustment for potential mediating factors in 
addition to demographic confounders are referred to as 
"fully adjusted" models. In the results section of Addi­
tional file 1, the findings from the fully adjusted models 
appear on the bottom row, while those from minimally 
adjusted models appear on the top row. Some studies in 
which CRP level was not the main outcome showed only 
unadjusted distributions of CRP levels without statistical 
analysis. A formal quantitative analyses of this association 
(a meta-analysis) was not performed because given varia­
bility in exposure and outcome definitions such analyses 
were not possible. Additional file 2 presents effect sizes 
from the studies, providing numerical description of the 
data when available. 
In the next sections we describe the main results of the 
studies reviewed. We comment on the statistical signifi­
cance of the findings and provide the effect sizes and con­
fidence intervals for the main analysis in each paper, 
when available in the publication. 
Socioeconomic status 
A wide range of socioeconomic factors were tested, the 
most common being level of formal education and social 
class, based on composite scores or proxy measures. A 
total of 77467 analyses were represented. The Greek and 
Scottish studies examined the same individuals more than 
once; the former used different indicators of SEP in each 
assessment. Some studies using representative national 
samples (National Health and Nutrition Examination 
Survey, NHANES) from the USA also examined data from 
the same group of individuals more than once. 
Of the 25 studies reporting on any SEP measure, nine pre­
sented only minimally adjusted results [20,26,33-39]; 12 
also presented fully adjusted models [40-51]; and four 
only presented the latter [52-55]. Of the 21 studies pre­
senting minimally adjusted results – 14 unadjusted and 
seven adjusted for demographic confounders – all but one 
showed inverse associations between SEP and CRP 
[20,26,33-37,39-51]. All 12 studies presenting both mini­
mally and fully adjusted analyses found inverse associa­
tions in the former; in five of these the magnitude of the 
association decreased and was no longer statistically sig­
nificant in the fully adjusted model [41,42,45,47,50]. The 
issue of whether the fully adjusted models may have 
included mediating factors is addressed in the Discussion. 
Of the 16 [40-55] studies presenting multivariable analy­
ses, nine found significant associations after adjusting for 
demographic, anthropometric and other postulated con­
founding variables [40,43,44,46,48,49,51,52,54]. 
One study using an unadjusted model [38] and seven 
using fully adjusted models [41,42,45,47,50,53,55] failed 
to find associations between any socioeconomic indicator 
and CRP. Direct associations were not found in any of the 
studies. 
Education and/or index measures were examined in 
nearly all studies. We present these findings below as sub­
groups of SEP analyses. 
Education 
Fourteen studies examined the effect of educational indi­
cators [20,33,35-37,40,42,43,45-47,49,52,53]. Of the 11 
presenting minimally adjusted results [20,33,35­
37,42,43,45-47,49] – six unadjusted and five adjusted for 
demographic variables – 10 found inverse associations, 
higher education being associated with lower CRP levels 
[20,33,35,37,42,43,45-47,49]. Three studies presenting 
only minimally adjusted results using NHANES data from 
1988–1994 included potentially overlapping samples 
[33,36,37], but are discussed below as separate studies. 
Among the nine studies that investigated this association 
in multivariable analysis [40,42,43,45-47,49,52,53], four 
found significant inverse associations with CRP levels 
after adjustment for postulated confounders such as age, 
smoking and body mass index (BMI = kg/m2) 
[40,46,49,52]. Three studies presenting fully adjusted 
results using NHANES data from 1999–2002 included 
potentially overlapping samples [40,52,53], but are dis­
cussed below as separate studies. 
Of the four studies showing significant inverse associa­
tions in the fully adjusted analyses, three presented 
detailed information on effect sizes. Panagiotakos et al. 
(2004) observed – in a model adjusted for demographic 
factors as well as BMI, smoking and other behavioral fac­
tors – a 45% lower mean CRP level among those who had 
studied at the university level as compared to those who 
had not. Ford et al. (2004) found a borderline association 
(p = 0.054) among women with less than a high school 
education, who presented with 0.17 mg/L (SE 0.09) 
higher lnCRP than those with more education. Loucks et 
al. (2005) observed a similar inverse trend in a multiple 
linear regression analysis; those with masters or doctoral 
degrees had a mean CRP (mg/L) level of 3.2 (95% CI 3.0– 
3.3) whereas those who had not completed high school 
presented a mean of 4.7 (95% CI 4.5–4.9). 
Of the five studies reporting fully adjusted analyses that 
showed non-significant results, four showed a trend 
towards an inverse association. Ford et al. (2003) found  Page 5 of 12 
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that men with less than a high school education had dou­
ble the regression coefficient for lnCRP than men with a 
high school diploma, although this association was not 
significant (β = 0.132, SE 0.096 and β = 0.065, SE 0.093) 
when smoking, BMI, alcohol intake and race/ethnicity 
were included in the model. Bo et al. (2005) found that 
those with secondary and university educations were pro­
tected against elevated CRP levels, but that these associa­
tions did not reach significance after adjustment for BMI, 
physical activity and smoking. Another study showed that 
those with post-secondary education had mean CRP lev­
els of 1.52 mg/L (SE 0.19) whereas those with less educa­
tion had 1.97 mg/L (SE 0.10) before body mass index 
(BMI) and waist-hip ratio (WHR) were included in statis­
tical models, attenuating these associations to the null 
[45]. Similarly, McDade et al. (2006) found that the 0.06 
mg/L reduction in lnCRP among those with higher educa­
tion was made non-significant when variables such as 
waist circumference and smoking were included in the 
model. 
Index measures 
Eleven studies used index measures, including the British 
social class system based on occupational status, to create 
socioeconomic scores or categories [26,38­
40,44,45,48,50,51,54,55]. Of the nine studies presenting 
minimally adjusted results [26,38-40,44,45,48,50,51] – 
five unadjusted and four adjusted for demographic varia­
bles – eight found inverse associations, increasing SEP 
being associated with lower CRP levels 
[26,39,40,44,45,48,50,51]. 
Among the eight studies that investigated this association 
in multivariable analysis [40,44,45,48,50,51,54,55], five 
found significantly increasing CRP levels with decreasing 
SEP [40,44,48,51,54]. These are discussed below. 
Mendall et al. (2000) found a significant inverse trend 
such that father's social class (as a proxy of childhood 
SEP) of IV (vs. I/II) was associated with a 33% (95% CI 4– 
69) relative increase in CRP levels among middle-aged 
men after adjusting for factors including age, BMI, smok­
ing, own social class and alcohol intake. A Finnish study 
showed that those with low and high SEP had geometric 
means of CRP of 2.11 and 1.63 mg/L in models adjusted 
for age, smoking, WHR and prevalent longstanding dis­
ease [44]. In a representative sample from the USA, Alley 
et al. (2005) showed that almost 16% of individuals from 
families living in poverty had elevated levels of CRP (>10 
mg/L), compared to 9% of the remaining subjects. Pana­
giotakos et al. (2005) reported similar results, with low 
and high SEP groups being associated with mean CRP lev­
els of 0.21 (SD 0.10) and 0.16 (SD 0.17) mg/L, respec­
tively. This finding remained significant after adjustment 
for age, sex, smoking, BMI, diet score and physical activity 
level. St. James O'Reilly (2006) found a significant 
increase in CRP levels such that in a model adjusted for 
age, smoking, BMI and use of medications, women, but 
not men, with a one unit increase in deprivation category 
had 4.8% (95% CI 0.4–9.5) higher levels of CRP. 
Of the three studies using multivariable analyses that 
showed non-significant results [45,50,55], two observed a 
trend towards an inverse association [45,50], while a third 
did not provide details [55], Kivimaki et al. (2005) found 
that parental and own SEP indicators showed inverse non­
significant trends with CRP after including BMI and WHR 
in statistical models. Rathmann et al. (2006) showed that 
CRP levels were inversely associated with SEP such that 
women with low and high SEP had geometric means of 
2.17 (SD 2.7) and 1.32 (SD 2.6) mg/L, respectively, which 
were significant in analyses adjusted for age, smoking, 
physical activity level and alcohol consumption, but 
decreased in significance to the borderline level when BMI 
and WHR were added to the model. 
Income and employment status 
Onat et al. (2001) reported that income was inversely 
associated with CRP levels in minimally adjusted models, 
among women significantly, but that this association lost 
significance in fully adjusted models [41], Alley et al. 
(2005) found that higher income was protective against 
moderately elevated CRP levels (1.1–3.0 mg/L) when 
adjusted for variables including age, sex, race/ethnicity, 
obesity and smoking; effect sizes were not provided. 
Four studies reported on variables related to employment 
status [34,36,43,45]. In minimally adjusted analyses, 
Mendall et al. (1996) found that father's, but not own 
occupation was inversely associated with CRP levels in 
men (effect sizes in next section). Using data from one city 
in the UK, Danesh et al. (1999) reported a trend in CRP 
tertiles according to employment status such that 56% of 
those in the highest CRP tertile were employed compared 
to 65% employed in the second and 74% in the lowest 
tertile. In the same study, however, type of job (manual or 
not) and four other socioeconomic indicators were not 
associated with CRP in minimally adjusted or fully 
adjusted models. In minimally adjusted analyses, Ford 
(2002) found that 57% (SE 1.5) of individuals in the ele­
vated CRP group (>= 85th percentile) had worked during 
the past two weeks whereas 68% (SE 0.7) in the non-ele­
vated (< 85th percentile) group had worked in the same 
period. Kivimaki et al. (2005) found that parental, but not 
own occupation showed inverse trends with CRP but that 
these associations were not significant in fully adjusted 
models including anthropometric variables (effect sizes 
above).  Page 6 of 12 
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Early life SEP 
Four studies examined early life socioeconomic factors 
with respect to CRP in adulthood [26,34,45,54]. In mini­
mally adjusted analyses, two British studies found inverse 
associations between CRP in adulthood and early life SEP. 
Mendall et al. (1996) found that father's occupation of 
75% (SE 5.6) of men in the highest quintile of median 
CRP was manual, compared to 61% (SE 6.3) in the lowest 
quintile. Lawlor et al. (2005) found an age-adjusted direct 
association between CRP and the number of adverse life-
course socioeconomic indicators: subjects with two 
adverse indicators presented a geometric mean CRP level 
of 1.4 mg/L (SEs not given) compared to 2.2 for those 
with eight indicators [26]. In fully adjusted models 
including age, sex, BMI and smoking, two European stud­
ies yielded conflicting results. A British study found an 
inverse association between father's social class and CRP 
levels in adulthood (effect sizes presented above, Mendall 
et al., 2000) while a Finnish study found a non-significant 
inverse trend (effect sizes previous section, Kivimaki et al., 
2005) [45,54]. 
Race and ethnicity 
The second part of this review addressed associations with 
variables related to race, ethnicity or skin color. Fifteen 
studies – twelve from the USA, two from the UK and one 
from Canada – examined CRP levels with respect to such 
variables [33,35,36,38,40,47,52,53,56-62]. A total of 
87285 analyses were represented and some studies used 
the same sample more than once, as discussed above. 
Six presented minimally adjusted results only 
[33,35,36,38,56,60] and nine [40,47,52,53,57-59,61,62] 
presented both minimally adjusted (seven unadjusted 
and two adjusted for demographic variables) and fully 
adjusted results. Thus, all 15 included studies presented 
minimally adjusted results, of which only one study failed 
to report significant associations [53]. Of the nine studies 
presenting fully adjusted results [40,47,52,53,57­
59,61,62], only one failed to show associations [53] and 
two found that these associations were no longer signifi­
cant after full adjustment, but that the direction of the 
effect was maintained [47,61]. The remaining six studies 
found that the associations remained significant in fully 
adjusted models. 
NHANES data 
Eight of the US studies used data from NHANES data sets 
[33,35,36,40,52,53,56,60], some with overlapping sam­
ples [33,36,56,60,52,53,40]. Seven reports presented 
minimally adjusted results and all but one [53] showed 
some significant associations between race/ethnicity and 
CRP level. Three of these studies [40,52,53] included fully 
adjusted models, of which two found significant associa­
tions [40,52]. All studies presenting significant findings 
reported higher CRP levels for blacks and Hispanics (or 
Mexican-Americans) as compared to whites. 
In all five studies that reported only minimally adjusted 
results [33,35,36,56,60], non-whites had significantly 
higher CRP levels than other groups. In comparing 95th 
percentiles among elderly white, black and Mexican-
Americans, Wener et al. (2000) showed that among men, 
Mexicans had the highest 95th percentiles (2.59 mg/dL, as 
presented in Wener et al., 2000; 95% CI not available due 
to missing information), followed by blacks (2.40 mg/dL) 
and then whites (1.24 mg/dL, 95% CI 0.84–1.64), with 
women following the same pattern. Wong et al. (2001) 
presented similar results, showing that the mean (SD) 
CRP levels among white, black and Mexican men were 
0.37 (0.52), 0.47 (0.75) and 0.39 (0.65) mg/dL; and 0.46 
(0.62), 0.61 (0.86) and 0.64 (1.32) mg/dL among 
women. Ford (2002) showed that whites composed 69% 
(SE 1.9) and 78% (SE 1.3) of the >= 85th and <85th percen­
tile of CRP levels, respectively. Abramson et al. (2002) 
found that African-Americans had 1.75 higher odds (cal­
culated from given distributions; no 95% CI available) of 
being in the elevated CRP group (>= 0.66 mg/dL) as com­
pared to whites. 
Danner et al. (2003) found African – and Mexican-Amer­
icans at higher risk for elevated CRP (>= 0.22 mg/dL) as 
compared to whites. The highest prevalence ratio (PR) 
compared to whites of the same sex was among African-
American men (PR = 1.57), followed by African – and 
Mexican-American women (PR = 1.44) and Mexican-
American men (prevalence ratio = 1.24, compared to 
white individuals of same sex, calculated from given dis­
tributions; no 95% CI available). 
Conflicting results were found in the three studies that uti­
lized fully adjusted models including age, sex, smoking 
and BMI among individuals aged at least 20 years. Ford et 
al. (2003) observed no associations between race/ethnic­
ity and CRP levels among men. In a 2004 study, the same 
author reported that Mexican-American women had on 
average 0.29 mg/L (SE 0.07) higher lnCRP levels than 
their white counterparts [52]. Alley et al. (2005) found 
that blacks had significantly higher odds of being in either 
the high (OR = 1.45 95% CI: 1.16–1.80) or very high (OR 
= 2.32 95% CI: 1.76–3.08) CRP groups as compared to 
other groups in fully adjusted models including demo­
graphic and lifestyle variables and BMI [40]. 
Other studies from North America and the UK 
Four studies from the USA, which did not use NHANES 
data, were included. One found median CRP levels of 3.0 
mg/L in blacks and 2.3 in whites of both sexes, which 
remained significant after adjusting for traditional cardio­
vascular risk factors [62]. In the same study, black men  Page 7 of 12 
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and women made up a significantly larger proportion of 
the high risk CRP group (>3 mg/L) than white men. Sim­
ilarly, Matthews et al. (2005) used a multi-community 
sample and found that after adjusting for variables such as 
education, physical activity and % calories from fat, Afri­
can-American, Hispanic and white women presented 
median (IQR) CRP levels of 3.0 (1.0–7.2), 2.3 (1.0–5.1) 
and 1.4 (0.6–3.9), respectively [58]. A small study among 
older individuals found no associations between blacks 
and whites, nor between Latinos and whites [47]. Another 
study using samples from multiple communities across 
the USA found that Hispanic men and women had the 
highest levels of CRP (2.51, 3.39, respectively), followed 
by African-Americans (2.12, 3.19), Caucasians (3.20, 
2.75) and Chinese (0.95, 1.20), after adjusting for covari­
ates including age, BMI, smoking, physical activity and 
estrogen medications [57]. Significance testing was not 
done between ethnic groups. 
Both studies from the UK found higher CRP levels among 
South Asians compared to European whites in minimally 
adjusted analyses [38,61]. Forouhi et al. (2001) observed 
that the median CRP level among South Asian women 
was 1.35 (95% CI 0.72–3.04) compared to half that level, 
0.70 mg/L (95% CI 0.41–1.7), among European women. 
This unadjusted association was significant; fully adjusted 
models were not used. In another UK study Chambers et 
al. (2001) showed that the age-adjusted association 
among the same ethnic groups lost significance after 
adjustment for age, BMI and smoking, but the direction of 
effect was maintained. The Canadian study found signifi­
cant differences between ethnic groups [59]. In fully 
adjusted models including BMI as a covariate, Chinese, 
European, South Asian and Aboriginals had mean CRP 
levels of 1.72 (SE 0.13), 2.13 (SE 0.12), 2.72 (SE 0.12) 
and 2.85 (SE 0.15) mg/L, respectively, with non-signifi­
cant differences between European and Chinese, and 
between South Asians and Aboriginals. 
Discussion 
The overwhelming majority of the 32 studies reported 
inverse associations between CRP levels and SEP and sig­
nificant differences among racial/ethnic groups, even after 
controlling for possible confounding and mediating vari­
ables. Individuals with African, Latin American or South 
Asian ancestry had higher levels than those with European 
background. Both sets of findings are consistent with pre­
vious studies showing similar associations between other 
CVD risk factors and SEP and race/ethnicity [3,4,8-10,63]. 
Although the notion that CRP levels are causally associ­
ated with CVD has been challenged by Mendelian Rand­
omization studies, there is little question that CRP 
constitutes a reliable marker for low-grade inflammation 
that identifies high-risk individuals [26,29]. 
Some strengths and limitations of this review warrant 
mention. It included studies using population-based stud­
ies, which minimizes selection bias. On the other hand, 
studies were largely from in high-income countries, nota­
bly from the USA and several European countries. The 
only low/middle-income country represented was Turkey; 
Onat et al. (2001) found inconsistent results. Further 
studies from low and middle-income countries are 
required to investigate whether the results from this 
review are also applicable to these regions. It is worth not­
ing that some studies excluded individuals with CRP lev­
els >10 mg/L (the cut-off for acute inflammation), which 
would make their results applicable only to low-level 
inflammation. 
When interpreting adjusted results, we gave special 
emphasis to differentiating possible confounders from 
mediating variables, based on a conceptual model (Figure 
1). In examining the association between SEP and CRP 
levels, adjustment for variables in level 1 of the model 
(age, sex and race/ethnicity, in addition to genetic factors) 
should account for confounding. None of the present 
studies adjusted for genetic markers, and these would 
only confound the association if they were unequally dis­
tributed among SEP groups. Also, several samples were 
ethnically homogeneous, rendering adjustment for this 
variable unnecessary. Therefore, for these studies adjust­
ment for age and sex should take care of the issue of 
known and measurable confounders. 
Of the 20 studies presenting minimally adjusted results, 
13 presented unadjusted analyses and seven presented 
results adjusted for demographic factors. All of the latter 
showed significant inverse associations between SEP and 
CRP. 
The fully adjusted models included age and sex in all stud­
ies, BMI in all but one (Matthews et al. 2005 used %kcal 
from fat) and smoking in all but one study [59]. Nine of 
21 studies did not adjust for hormone replacement ther­
apy (HRT) use [40,41,46-51,59]. Thus, five common var­
iables were adjusted for in most studies (age, sex, BMI, 
smoking and HRT). Therefore, the fully adjusted model in 
nearly every study included both confounding (age, sex) 
and potentially mediating (BMI, smoking, HRT) varia­
bles. These analyses answer the question "what is the 
effect of SEP on CRP levels that does not pass through the 
mediating factors that are in the model?", not the ques­
tion of the overall effect of SEP. 
The persistence of significant associations in most fully 
adjusted analyses suggest that low SEP is a risk factor for 
elevated CRP levels (although not necessarily cardiovas­
cular risk), even when some of the potential mediators of 
this association are controlled for. It also suggests that  Page 8 of 12 
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there are other pathways by which SEP may affect CRP lev­
els [30]. For example, it has been postulated that high lev­
els of stress accumulated throughout the life-course, 
which is often the case among the poor and disadvan­
taged, may adversely impact health outcomes [64,65]. 
Socioeconomic status in childhood, independently of 
adult socioeconomic conditions, has been shown to be 
associated with mortality among adults, indicating spe­
cific effects of early deprivation [66]. Four studies 
included in this review suggest a similar association 
between early SEP and CRP levels. The only exception was 
a high-quality Finnish study which reported a significant 
association in age and sex-adjusted analyses that lost sig­
nificance after adjustment for BMI and WHR, that accord­
ing to our framework represent possible mediating factors 
[45]. It is likely that adverse features are programmed in 
intrauterine and early life under conditions of poor SEP 
during physiologically plastic periods and track into 
adulthood, manifesting as increased risk for disease, 
regardless of later improvement of socioeconomic condi­
tions [64,67,68]. 
The findings on racial/ethnic groups are now addressed. 
The range of ethnicities represented in the studies was rel­
atively limited. In studies from the UK, only European 
whites and South Asians comprised the study samples, 
whereas in studies from the USA, four general categories 
were presented (white, black/African-American, Hispanic/ 
Mexican-American and other). Canadian studies were 
more diverse, including Aboriginals, Europeans and at 
least two Asian groups (eg: Chinese, Japanese, South 
Asian). 
In terms of the conceptual model (Figure 1), the effects of 
race/ethnicity on CRP levels may be confounded by other 
level 1 variables (age, sex and genetic factors) [69]. 
Because non-whites tend to have poorer education and 
income than whites in North America and Europe, SEP 
can legitimately be considered a potential mediating fac­
tor in the association between ethnicity and health-related 
outcomes [70-72]. Models that adjust for SEP, therefore, 
are answering the question on what the effect of race/eth­
nicity is on CRP that is not mediated by SEP. Models that 
further adjust for level 3 variables (such as BMI, smoking, 
etc) are answering the question of what effect of race/eth­
nicity remains outside these pathways. 
Both in the minimally and fully adjusted models, findings 
on the association between race/ethnicity and CRP were 
highly consistent. In studies from North America, blacks 
and Hispanics tended to have higher CRP than whites, 
and individuals of East Asian descent (Chinese, Japanese) 
tended to have the lowest levels. In UK studies, South 
Asians were shown to have higher levels of CRP than 
European whites. The high CVD rates among black Amer­
icans and South Asians in Europe are consistent with these 
findings on CRP [9]. 
Conclusion 
Socioeconomic status was independently and inversely 
associated with CRP levels among adults in several high-
income countries. Studies regarding the effects of early life 
and adult SEP on risk factors such as CRP are still needed, 
especially from low and middle-income countries. 
Race/ethnicity was independently associated with CRP 
levels such that those of African, Latin or South Asian 
descent were at higher risk for elevated CRP than subjects 
of European descent. Given the complex inter-relation­
ships between exposures, confounding and mediating 
variables, racial/ethnic determinants of disease can be dif­
ficult to study and interpret [73]. Nevertheless, collabora­
tive studies from multiple countries may lead to increased 
insight regarding the effects of these variables on risk fac­
tors and disease outcomes. 
A full understanding of the associations between SEP and 
race/ethnicity on the one hand, and CRP on the other, was 
precluded by the fact that nearly all studies included sta­
tistical adjustment for variables that are likely mediating 
factors in this causal pathway. The fact that most studies 
show significant results despite such over adjustment is 
reassuring, but the true magnitude of these associations is 
being underestimated. Epidemiological studies address­
ing what has been described as the "causes of causes", that 
is, the distal determinants of health and disease, would 
greatly profit from the use of conceptual models spelling 
out causal pathways that allow to differentiate confound­
ing from mediating factors [74,75]. 
These findings indicate that poorer, non-white individu­
als are the highest risk for elevated CRP levels. This is con­
sistent with previous data showing that these groups have 
elevated incidence and prevalence of almost all disease 
states. Scientists and policy makers should capitalize upon 
results from the host of studies that have already con­
firmed such associations in attempts to curb the growing 
incidence of chronic disease caused by low SEP and ever-
increasing socioeconomic gaps [76]. 
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